Nanobiotix Stock Plummets 10.35% After Tenfold Increase Over the Year
Nanobiotix experiences a significant decline this Wednesday, March 11, with its share price falling by 10.35% to €29.45 during the session, after closing at €32.85 the previous day. This sharp movement occurs in a context of pressured European markets, with the CAC 40 down by 0.58% and the DAX dropping 1.58% during the session. The Parisian biotech, whose stock has increased nearly tenfold in a year, thus faces a notable setback.
Significant Correction Amidst Market Volatility
Nanobiotix's stock price stands at €29.45 this Wednesday, undergoing a severe correction and erasing some of the gains accumulated over the past week, during which the stock had still advanced by nearly 12%. Over three months, the stock maintains an increase of 52.59%, and over a year, the performance reaches 881.7%, reflecting a rarely seen bullish trajectory on the Paris stock exchange. This decline occurs as major European indices are in negative territory. The SBF 120, which includes this stock, is down 0.60% during the session. The FTSE 100 in London also drops by 0.74%. In contrast, Tokyo's Nikkei 225 ended the day up by 1.43% at its close. The VIX, a volatility indicator on the American markets, remains at a high level of 29.49 points, signaling a persistently tense environment on global financial markets.
Technical Analysis Highlights Overheating Signals
In today's session, Nanobiotix's share price has fallen below the upper Bollinger band, set at €32.64, after briefly exceeding it. This rise and subsequent fall are classic signals of short-term overheating. The Relative Strength Index (RSI), which measures the intensity of recent movements of the stock, is at 81, well above the usual overbought threshold of 70. This level suggests that the recent progression has been particularly rapid. Nevertheless, the stock is trading significantly above its 50-day and 200-day moving averages, established at €20.81 and €13.76 respectively, indicating the strength of the underlying bullish trend. The nearest resistance threshold is at €33.50, a level the stock has not managed to sustainably surpass, while the identified technical support lies much lower, at €17.46. The monthly volatility, measured at 22.72%, confirms the magnitude of the fluctuations to which the stock is currently exposed.
